Core Viewpoint - Ecolab Inc. reported strong year-over-year growth in both adjusted earnings per share (EPS) and revenue for the third quarter of 2024, despite some mixed results across its segments [1][13]. Revenue Details - Ecolab's revenues for the third quarter reached $3.99 billion, reflecting a 1% increase year over year, but fell short of the Zacks Consensus Estimate by 0.8% [2] - Organic sales increased by 3.9% year over year, driven by strong growth in the Institutional & Specialty and Industrial segments [2]. Segmental Analysis - The sale of Ecolab's global surgical solutions business to Medline for approximately $950 million in cash was completed in August, but the company continues to serve hospitals through its infection prevention and instrument reprocessing businesses [3]. - The Global Industrial segment reported fixed currency sales of $1.99 billion, showing a 2.7% growth year over year, with organic sales up 2% due to strong Water sales growth [4]. - The Global Institutional & Specialty segment's fixed currency sales were $1.40 billion, reflecting a 6.8% growth, driven by robust performance in Institutional and Specialty businesses [5]. - The Global Healthcare and Life Sciences segment saw fixed currency sales decline by 18.2% to $334.1 million, primarily due to the surgical solutions business sale, although organic sales increased by 0.7% [6]. - The Global Pest Elimination segment's fixed currency sales improved by 9% to $308.7 million, with organic sales up 7.8% driven by growth in food & beverage and retail [7]. Margin Analysis - Ecolab's gross profit increased by 6.7% year over year to $1.74 billion, with gross margin expanding by 230 basis points to 43.4% [8]. - Adjusted operating profit rose by 17.2% to $713.1 million, with adjusted operating margin expanding by 250 basis points to 17.9% [8]. Financial Position - At the end of the third quarter, Ecolab had cash and cash equivalents of $1.26 billion, up from $384 million at the end of the second quarter [9]. - Total debt increased to $7.62 billion from $7.54 billion at the end of the second quarter [9]. - Net cash provided by operating activities was $786.7 million, slightly down from $787.7 million a year ago [10]. Guidance - Ecolab expects adjusted EPS for the fourth quarter of 2024 to be in the range of $1.75-$1.85, representing a 13-19% increase from the previous year [11]. - For the full year 2024, adjusted EPS is now expected to be in the range of $6.60-$6.70, reflecting a 27-29% increase from 2023 [12]. Overall Assessment - Ecolab's third-quarter results showed a robust year-over-year increase in both top and bottom lines, with solid performances across most segments [13]. - The company anticipates continued sales growth driven by value pricing and new business gains, alongside margin expansion [14].

Core Insights - Ecolab reported $4 billion in revenue for Q3 2024, a year-over-year increase of 1%, with an EPS of $1.83 compared to $1.54 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $4.02 billion, resulting in a surprise of -0.65%, while the EPS exceeded expectations by +0.55% [1] Revenue Performance - Global Healthcare and Life Sciences sales were $334.10 million, below the estimated $330.73 million, reflecting a -16.6% change year-over-year [3] - Global Industrial sales reached $1.97 billion, slightly below the $2 billion estimate, showing a +6.8% year-over-year increase [3] - Global Institutional & Specialty sales were $1.39 billion, matching the analyst estimate, with a +6.2% year-over-year change [3] - Global Pest Elimination sales were $307.20 million, slightly below the estimate of $307.44 million, indicating a -19.6% year-over-year decline [3] - Global Healthcare & Life Sciences (Public Currency rates) sales were $330.40 million, significantly lower than the $363.51 million estimate, representing an -18.7% change year-over-year [3] Operating Income - Global Industrial operating income was $342.70 million, exceeding the average estimate of $332.85 million [3] - Global Pest Elimination operating income was $62.80 million, below the estimate of $64.71 million [3] - Global Institutional & Specialty operating income was $322.80 million, slightly below the average estimate of $324.72 million [3] Stock Performance - Ecolab shares returned +0.4% over the past month, underperforming the Zacks S&P 500 composite's +1.7% change [4] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [4]

Ecolab (ECL) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.54 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 0.55%. A quarter ago, it was expected that this cleaning, food-safety and pest-control services company would post earnings of $1.66 per share when it actually produced earnings of $1.68, delivering a surprise of 1.20%. Over ...

Exhibit 99.1 News Release Investor Contact: Media Contact: Andrew Hedberg (651) 250-2185 Nigel Glennie (651) 250-2576 Cairn Clark (651) 250-2291 ECOLAB DELIVERS CONTINUED STRONG GROWTH IN THE THIRD QUARTER REPORTED DILUTED EPS $2.58; ADJUSTED DILUTED EPS $1.83, +19% INCREASED 2024 ADJUSTED DILUTED EPS OUTLOOK: $6.60 - $6.70, +27% - 29% THIRD QUARTER HIGHLIGHTS ● Reported sales $4.0 billion, +1% versus last year including a 2% headwind from the sale of the global surgical solutions business and a 1% headwind ...

Ecolab, Inc. (ECL) is scheduled to report third-quarter 2024 results on Oct. 29, 2024, before the opening bell.In the last reported quarter, the company’s earnings per share (EPS) of $1.68 surpassed the Zacks Consensus Estimate by 1.2%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 0.98%, on average.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Let’s see how things have shaped up for Eco ...

Wall Street analysts forecast that Ecolab (ECL) will report quarterly earnings of $1.82 per share in its upcoming release, pointing to a year-over-year increase of 18.2%. It is anticipated that revenues will amount to $4.02 billion, exhibiting an increase of 1.7% compared to the year-ago quarter.The current level reflects an upward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their in ...

Ecolab Inc. (ECL) has been gaining from its solid product portfolio. The optimism, led by a solid second-quarter 2024 performance, along with solid long-term growth prospects, is expected to contribute further. However, concerns arising from cost fluctuations persist.This Zacks Rank #3 (Hold) stock has rallied 30.2% year to date against the industry’s 11.3% decline. The S&P 500 Composite has increased 22.8% during the same time frame.The renowned water, hygiene and infection prevention solutions and service ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ecolab (ECL) , which belongs to the Zacks Chemical - Specialty industry, could be a great candidate to consider. This cleaning, food-safety and pest-control services company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 0. ...

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying stocks that can fulfill this potential is challenging [1] Group 1: Company Overview - Ecolab (ECL) is currently recommended as a growth stock by the Zacks Growth Style Score system, which evaluates a company's real growth prospects beyond traditional metrics [2] - Ecolab has a favorable Growth Score and a top Zacks Rank, indicating strong growth potential [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being highly desirable [3] - Ecolab's projected EPS growth for this year is 27.7%, significantly higher than the industry average of 9.5% [4] Group 3: Cash Flow Growth - Higher-than-average cash flow growth is essential for growth-oriented companies, allowing them to expand without relying on external funding [5] - Ecolab's year-over-year cash flow growth is 8.6%, outperforming the industry average of -5.7% [5] - The company's historical annualized cash flow growth rate over the past 3-5 years is 1.3%, slightly above the industry average of 1.1% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions are correlated with stock price movements [7] - Ecolab's current-year earnings estimates have been revised upward, with the Zacks Consensus Estimate increasing by 0.1% over the past month [7] Group 5: Investment Positioning - Ecolab has achieved a Growth Score of B and a Zacks Rank 2 due to positive earnings estimate revisions, positioning it well for potential outperformance [8]

Ecolab (ECL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Since a chang ...